Childress Capital Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,585
Closed -$750K 397
2026
Q1
$750K Sell
1,585
-166
-9% -$83.6K 0.14% 112
2025
Q4
$818K Buy
1,751
+824
+89% +$383K 0.13% 110
2025
Q3
$395K Buy
927
+322
+53% +$125K 0.07% 182
2025
Q2
$232K Buy
+605
New +$218K 0.06% 222
2023
Q1
Sell
-1,011
Closed -$243K 125
2022
Q4
$243K Buy
+1,011
New +$226K 0.08% 154
2022
Q2
Sell
-906
Closed -$228K 180
2022
Q1
$228K Buy
+906
New +$228K 0.08% 167
2021
Q1
Sell
-369
Closed -$61K 495
2020
Q4
$61K Buy
+369
New +$54K 0.04% 194

Other funds holding HCA

Childress Capital Advisors's HCA Position: Q2 2026 in Review

Childress Capital Advisors sold out of HCA Healthcare (HCA) in Q2 2026, closing a stake of 1,585 shares — an estimated $750K sold.

Childress Capital Advisors first reported a position in HCA in Q4 2020 and held it in 7 quarters. The position peaked at $818K in Q4 2025. 379 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Childress Capital Advisors reported no remaining HCA Healthcare position as of Q2 2026 after selling out during the quarter.
  • Childress Capital Advisors sold 1,585 HCA Healthcare shares in Q2 2026, an estimated $750K.
  • Childress Capital Advisors first reported a position in HCA Healthcare in Q4 2020 and held it in 7 quarters.
  • Childress Capital Advisors's HCA Healthcare position peaked at $818K in Q4 2025.
  • 379 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Childress Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.